1st Quarter - Report

ELANCO ANIMAL HEALTH INCORPORATED for ELANCO ANIMAL HEALTH INCORPORATED

Firm
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

Issues related to carbon market development. Issues related to environmental regulations and conservation.

LobbyistCovered position, as disclosed
ANNE KEYS —
JESSE SEVCIK —
JOHN MARSHALL STEWART —

Contacted: SENATE; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); White House Office; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Agriculture AGR

Discussions related to the Farm Bill Discussions related to the Inflation Reduction Act Issues related to sustainability - no specific legislation Discussions related to the CHIPS and Science Act (PL 117-167)

LobbyistCovered position, as disclosed
ANNE KEYS —
JESSE SEVCIK —
JOHN MARSHALL STEWART —

Contacted: White House Office; SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Trade (domestic/foreign) TRD

Discussions related to removing non-tariff barriers to US agricultural exports at the WTO. Discussions related to trade between the US and Greater China. Discussions related to trade between the US and EU. Discussions related to international trade standards (ex. Codex Alimentarius, WOAH) Sanitary and Phytosanitary (SPS) discussions, no specific legislation. Discussions related to supply chain resilience.

LobbyistCovered position, as disclosed
ANNE KEYS —
JESSE SEVCIK —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); SENATE

Animals ANI

Supporting the Innovative FEED Act, S. 1842 and HR 6687. Issues related to animal health, veterinary medicine, and antimicrobial resistance- no specific legislation. Issues related to veterinary biologics, biotechnology- no specific legislation. Issues related to protection against zoonotic disease- no specific legislation.

LobbyistCovered position, as disclosed
ANNE KEYS —
JESSE SEVCIK —
JOHN MARSHALL STEWART —

Contacted: U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); White House Office; Agriculture, Dept of (USDA); SENATE; Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 6687 (118th), S. 1842 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.